Cross-species RNAi therapy via AAV delivery alleviates neuropathic pain by targeting GCH1.
Chang H, Lee KJ, Park M, Woo HN, Kim JH, Kang IK, Park H, Chon CH, Lee H, Jung HH.
Chang H, et al. Among authors: park h, park m.
Neurotherapeutics. 2024 Dec 14:e00511. doi: 10.1016/j.neurot.2024.e00511. Online ahead of print.
Neurotherapeutics. 2024.
PMID: 39674763
Free article.